New Platinum and Ruthenium complexes display antitumour and antimetastatic potentials and lower host toxicities. This mini-review examines some the more recent developments in this field, and explores their interactions with biologically-relevant species. The article also refers to more recent work in the area of molybdenum and copper(II) chemistry.
Keywords: Cisplatin, BBR3464, picoplatin, satraplatin, lipoplatin, NAMI-A, KP1019, RAPTA, cancer, chemotherapeutics
Rights & PermissionsPrintExport